Gear up for the change! MoonLake Immunotherapeutics (MLTX) has hit the volume of 119058
... 2022, MoonLake Immunotherapeutics screens first patient in Phase 2 study of the Nanobody® sonelokimab in active psoriatic arthritis. ... 2022, MoonLake Immunotherapeutics screens first patient in Phase 2…